Screener
Bausch + Lomb BLCO Surgical — Selling, general and administrative (Note 4)
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bausch + Lomb in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The source filing: Bausch + Lomb’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001860742-26-000088
| (in millions) | Vision Care / Three Months Ended June 30, 2026 | Vision Care / Three Months Ended June 30, 2025 | Pharmaceuticals / Three Months Ended June 30, 2026 | Pharmaceuticals / Three Months Ended June 30, 2025 | Surgical / Three Months Ended June 30, 2026 | Surgical / Three Months Ended June 30, 2025 | Total / Three Months Ended June 30, 2026 | Total / Three Months Ended June 30, 2025 |
|---|---|---|---|---|---|---|---|---|
| Expenses | ||||||||
| Cost of goods sold (excluding amortization and impairments of intangible assets) | 291 | 290 | 89 | 104 | 147 | 129 | ||
| Cost of other revenues | — | — | — | 2 | — | — | ||
| Selling, general and administrative | 247 | 243 | 149 | 154 | 80 | 73 | ||
| Research and development | 17 | 11 | 27 | 12 | 12 | 12 | ||
| Segment Profit | $229 | $209 | $89 | $37 | $17 | $2 | 335 | 248 |
| Corporate | (170) | (170) | ||||||
| Amortization of intangible assets | (57) | (67) |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Bausch + Lomb's surgical — selling, general and administrative (note 4)?
- Bausch + Lomb (BLCO) reported surgical — selling, general and administrative (note 4) of $80M in Q2 2026.
- How has Bausch + Lomb's surgical — selling, general and administrative (note 4) changed year-over-year?
- Bausch + Lomb's surgical — selling, general and administrative (note 4) increased by 9.6% year-over-year, from $73M to $80M.
- What is the long-term trend for Bausch + Lomb's surgical — selling, general and administrative (note 4)?
- Over 3 years (2022 to 2025), Bausch + Lomb's surgical — selling, general and administrative (note 4) has grown at a 8.9% compound annual growth rate (CAGR), from $231M to $298M.
- What does surgical — selling, general and administrative (note 4) mean?
- Includes the operating expenses related to the sales force, marketing, and administrative overhead required to support the surgical business segment. This metric measures the efficiency of the segment's support structure and commercial operations. Monitoring this relative to revenue helps assess the operating leverage of the surgical division.
Ask your AI about Bausch + Lomb's surgical — selling, general and administrative (note 4).
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude